A Three-Year Supply Strategy Under Margin Pressure

Translate, then segment, then choose.

Step 1: translate each corporate goal into a supply outcome.

• 8% growth requires capacity to scale, supplier-led innovation, and no revenue interruption. Growth makes risk expensive: $11 million of lost sales on a $900 million base is 1.2% of revenue gone from one part.
• 250 bps of gross margin is roughly $22.5 million at current revenue. Supply's realistic contribution is cost reduction on addressable spend, design-to-cost with R&D, payment terms, and freight, so I would plan $9-11 million and say so rather than overclaim.
• 99% service requires supplier OTIF, buffer strategy on critical items, and documented business continuity coverage.

Step 2: a risk-adjusted baseline, not just a spend cube. The top 40 suppliers are $291 million, or 71% of spend. Segment on Kraljic, then overlay revenue-at-risk. The silicone valve is not the largest spend line but is the highest revenue-at-risk item in the company. That distinction is the heart of the strategy, because a spend-ranked portfolio systematically under-resources it.

Step 3: five pillars.

1. Protect revenue: remove single points of failure in the top five revenue-at-risk items.
2. Category strategies for the $291 million strategic and leverage portfolio, with should-cost on the top 20.
3. A cost program delivering $9-11 million by year three, tracked against baseline prices and verified by finance.
4. Supplier performance and development through a tiered SRM model for the top 40.
5. Capability and data: category management skills, spend analytics, a contract repository.

Step 4: governance. Each pillar has an owner, a KPI, a budget, and year-by-year milestones, reviewed quarterly with the CFO and annually with the board.

What makes it a strategy rather than a wish list: stated trade-offs. I would explicitly accept a higher unit price on two critical components to remove single-source exposure, and show the number that justifies it.

Year 1: fund risk reduction from savings, not from new money.

1. Second source for the silicone valve. Budget $900k-$1.2 million for tooling, validation, and regulatory work. Flag the regulatory reality up front: changing the molding site for a medical device can require a 510(k) or a PMA supplement, adding 12-18 months. Start in month one and run it through regulatory affairs, not procurement alone.
2. Interim hedge. Carry 8-10 weeks of valve inventory. At typical carrying costs that is a few hundred thousand dollars a year against an $11 million exposure, a cheap bridge while qualification runs.
3. Leverage categories. Should-cost models and renegotiation on the top 10 non-single-source suppliers, targeting $6 million of year-one run-rate savings. This funds everything else and is what makes the strategy self-funding with the CFO.
4. Tail consolidation. 640 down to 450 suppliers, targeting $1.2 million from price and process cost, executed in the second half.

Year 2: structural resilience. Complete dual-source qualification; add capacity reservation, tooling ownership, and last-time-buy clauses to the valve contract; put business continuity terms into the top 10 agreements; embed design-for-resilience into the new product gate process with R&D so the next platform does not repeat the single-mold decision.

Year 3: depth. Supplier development for the top 15, digital SRM and scorecards, should-cost extended to 60% of spend, and a sustainability program aligned to customer requirements.

Resourcing from 26 staff. Reallocate three FTE to risk and SRM, hire one senior category manager for the valve program, and use a third party for year-one should-cost work. Discretionary spend stays inside $4 million if the risk program is phased: roughly $1.8M in year one (tooling plus inventory), $1.2M in year two, $0.6M in year three.

Deliberately deferred: a full e-sourcing suite and supplier portal. Useful, but not before the revenue-at-risk problem is closed.

Reframe from resilience to expected loss. Resilience is an insurance premium, and CFOs fund premiums when the loss distribution is quantified.

The calculation with our numbers.

• Observed loss: $11 million from a six-week disruption.
• Frequency assumption: even at a 20% annual probability, the three-year expected loss is roughly $6.6 million, before any growth effect, which makes it worse.
• Cost of the fix: about $1.2 million for second-source qualification plus a few hundred thousand a year for the buffer.
• Risk-adjusted return: if the second source removes 70% of exposure, expected loss avoided over three years is roughly $4.6 million against about $2 million of cost.

Three things that make it approvable.

1. Self-funding sequence. The $6 million of leverage-category savings in year one covers the valve program. Resilience is not competing with the 250 bps target; it is funded by the same plan, shown on one page.
2. Insurance, not preference. Present a defined coverage level: 70% of volume dual-sourced and eight weeks of buffer on the top five revenue-at-risk items, with a stated premium. A CFO can negotiate a coverage level; she cannot negotiate a philosophy.
3. The downside of doing nothing. A second outage on 62% of revenue also puts the 8% growth target out of reach, which makes this a board issue, not a procurement issue.

What I would not do. Argue the intrinsic value of resilience, or present a plan requiring new money in a margin-constrained year. And avoid false precision: label the probability as an assumption, show what changes at 10% versus 30%, and let the CFO choose the number she is willing to defend.